Participations à des congrès et colloques internationaux (50)

  1. 22. D'Haene, N., Sauvage, S., Maris, C., Trepant, A.-L., Le Mercier, M., Decaestecker, C., & Salmon, I. (2011). Involvement of Vascular Endothelial Growth Factor Receptors in Endothelial Cell Response to Galectin-1 and Galectin-3. Journal Of Pathology: Ghent Pathology 2011. Vol. Volume 224, Issue S2 (pp. S15-S16) Abstract session presented at 6th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland(May 2011).
  2. 23. Ferdinande, L., Mathieu, A., Decaestecker, C., Negulescu, A., Cuvelier, C. A., Salmon, I., & Demetter, P. (2010). Indoleamine 2,3-dioxygenase expression is an independent prognostic factor in pT1-4N1Mx staged colorectal cancer. Paper session presented at Gastrointestinal Cancers Symposium Rabat (January,2010).
  3. 24. Wauthoz, N., Deleuze, P., Hecq, J., Roland, I., Saussez, S., Adanja, I., Debeir, O., Decaestecker, C., Mathieu, V., Kiss, R., & Amighi, K. (2009). In vivo assessment of temozolomide delivery systems for inhalation therapy of lung cancer. Paper session presented at Journée doctorale Pôle Santé (17/12/2009: Campus Erasme).
  4. 25. Megalizzi, V., Lefranc, F., Debeir, O., Decaestecker, C., & Kiss, R. (2009). Screening of sigma-1 ligand-induced effects on glioma cell aggressiveness in vitro and in vivo: new therapeutic potential of old anti-psychotic medicines. Poster présenté à la conférence 100th American Association for Cancer Research Annual Meeting (Abstract 852: Denver - CO - USA).
  5. 26. Lefranc, F., Spiegl-Kreinecker, S., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Berger, W., & Kiss, R. (2008). Temozolomide displays anti-migratory effects in human glioblastoma cells through neuregulin down-regulation. Poster présenté à la conférence American Association for Cancer Research Annual Meeting (99th: April 12-16: San Diego - USA).
  6. 27. Nortier, J., Pozdzik, A., Salmon, I., Decaestecker, C., Van den Branden, C., Verbeelen, D., Deschodt Lanckman, M., & Vanherweghem, J.-L. (2008). Aristolochic acid induces proximal tubule apoptosis, EMT and interstitial cell infiltration. Paper session presented at ACIR meeting (8 Juillet 2008: Heidelberg, Germany).
  7. 28. Pozdzik, A., Salmon, I., Debelle, F. D., Decaestecker, C., Van den Branden, C., Deschodt Lanckman, M., Vanherweghem, J.-L., & Nortier, J. (2008). Aristolochic acid induces proximal tubule apoptosis, epithelial to mesenchymal transformation and immuncompetents cells infiltration. Paper session presented at World Health Organisation (WHO) symposia and Workshop of diagnostic criteria's of Balkan Endemic nephropathy (18 Avril 2008: Bol, Croatie).
  8. 29. Pozdzik, A., Salmon, I., Debelle, F., De Prez, E., Decaestecker, C., Van den Branden, C., Verbeelen, D., Deschodt Lanckman, M., Vanherweghem, J.-L., & Nortier, J. (2007). Early intratubular epithelial to mesenchymal transition (EMT) after aristolochic acid intoxication. Paper session presented at Annual meeting of the Belgian Society of Nephrology (8 mars 2007: Bruxelles).
  9. 30. Pozdzik, A., Salmon, I., Husson, C., Decaestecker, C., Rogier, E., Bourgeade, M.-F., Deschodt Lanckman, M., Vanherweghem, J.-L., & Nortier, J. (2007). From aristolochic acid intoxication to renal fibrosis: activated macrophages and CD8+CD103+ T lymphocytes are key effectors. Paper session presented at Annual meeting of the Belgian Society of Nephrology (8 mars 2007: Bruxelles).
  10. 31. Debeir, O., Van Ginckel, R., Adanja, I., Darro, F., Kiss, R., & Decaestecker, C. (2007). High throughput characterization of anticancer compounds by means of cellular imaging and automatic image analysis. American Association for Cancer Research Annual Meeting Abstract session presented at (April 14-18: Los Angeles - USA)
  11. 32. Le Mercier, M., Kondo, Y., Mathieu, V., Camby, I., Decaestecker, C., Kiss, R., & Lefranc, F. (2007). Decreasing galectin-1 expression in human experimental glioblastomas impairs the endoplasmic reticulum stress (ERS) response and increases temozolomide anti-tumor effects. Poster présenté à la conférence American Association for Cancer Research Annual Meeting (97th: April 14-18: Los Angeles - USA).
  12. 33. Le Mercier, M., Lefranc, F., Mijatovic, T., Debeir, O., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Kiss, R., & Mathieu, V. (2007). Galectin-1 regulates p53 and is implicated in glioma cell resistance to cytotoxic drugs. Proceedings of the Belgium Society for Cell and Developmental Biology Autumn Meeting: Oxygen and Reactive Oxygen Species in Biology Abstract session presented at Belgium Society for Cell and Developmental Biology Autumn Meeting(Louvain-la-Neuve)

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>